Qiang Chen
Director/Board Member bij CHINA HAISUM ENGINEERING CO., LTD.
Profiel
Qiang Chen currently works at China Haisum Engineering Co., Ltd., as Independent Director from 2023, Jiangsu Huachang Chemical Co., Ltd., as Independent Director from 2023, and Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd., as Independent Director from 2022.
Actieve functies van Qiang Chen
Bedrijven | Functie | Begin |
---|---|---|
CHINA HAISUM ENGINEERING CO., LTD. | Director/Board Member | 18-05-2023 |
JIANGSU HUACHANG CHEMICAL CO., LTD | Director/Board Member | 22-08-2023 |
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Director/Board Member | 01-01-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CHINA HAISUM ENGINEERING CO., LTD. | Industrial Services |
JIANGSU HUACHANG CHEMICAL CO., LTD | Process Industries |
Bedrijven in privébezit | 1 |
---|---|
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd.
Shanghai Shengsheng Pharmaceutical Cold Chain Tech Co., Ltd. Air Freight/CouriersTransportation Shanghai Shengsheng Pharmaceutical Cold Chain Technology Co., Ltd. engages in the provision of biopharmaceutical cold chain services. It operates under the following segments: innovative drug research and development and life science cold chain services, cold chain logistics for commercial circulation of medicine and equipment, international pharmaceutical cold chain service, cell therapy cold chain service, and sales of new materials and cold chain equipment segment. The company was founded on August 7, 2017 and is headquartered in Shanghai, China. | Transportation |